Suspected adverse reactions to medicines including those received in clinical trials can also be reported via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk
Rising Global Prevalence of Type 2 Diabetes and Obesity The rising global prevalence of type 2 diabetes and obesity is boosting the need for the GLP-1 receptor agonist, as these conditions represent the primary therapeutic targets for this drug class
Methaemoglobinaemia and the radical curative efficacy of 8-aminoquinoline antimalarials
C Lan 55 tui: Mnh nh gi vin ung Glutathione 600 Dr Lacir l sn phm kh tt, ph hp vi nhng ngi c nhu cu lm trng da, m nm, tn nhang
Always follow your clinic, provider, or lab protocol guidance
The goal of this study was to compare the efficacy and safety of NASO B12 with oral methylcobalamin tablets in treating the deficiency of vitamin B12 in patients receiving metformin for the management of diabetes